Accelerated phase (AP) and blastic crisis (BC) CML patients were reported to express higher MDR1 expression compared to chronic phase (CP) CML patients supporting these findings (Solali et al. 2013). Here, ABCB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.